Bittl J A, Pfeffer M A, Lewis R A, Mehrotra M M, Corey E J, Austen K F
Cardiovasc Res. 1985 Jul;19(7):426-32. doi: 10.1093/cvr/19.7.426.
Leukotrienes C4 and D4 (LTC4 and LTD4), possible mediators of cardiac dysfunction during inflammatory injury, may depress cardiac function by reducing coronary flow or by exerting a negative effect directly on the myocardium. We used an isovolumic rat heart preparation perfused at constant pressure and measured left ventricular developed pressure (mmHg), coronary flow (ml.min-1), oxygen extraction, and myocardial oxygen consumption and delivery (mumol O2.[gramme dry weight]-1.min-1) during infusion of five doses of angiotensin II, LTC4, LTD4 (approximately 10 to approximately 300 pmol.min-1), and noradrenaline (400 to 2000 pmol.min-1), or perfusion with medium which contained calcium at half-concentration. LTC4 and LTD4 were equipotent with angiotensin. At low effective doses, increased oxygen extraction offset the decrease in oxygen delivery, maintaining a stable level of oxygen consumption and left ventricular developed pressure. At the highest doses, angiotensin, LTC4 and LTD4 reduced coronary flow from 21 to 15, 21 to 13, and 21 to 13 ml.min-1, respectively. And, despite greater oxygen extraction of 59%, 58% and 65% for angiotensin, LTC4 and LTD4, left ventricular developed pressure fell from a baseline of 120 mmHg to 113, 106 and 92, respectively. In contrast, low calcium perfusion reduced left ventricular developed pressure (126 to 92) and oxygen extraction (46 to 30%) without changing coronary flow or oxygen delivery. These results suggest that LTC4 and LTD4 are potent coronary vasoconstricting agents which depress cardiac function by limiting oxygen delivery.
白三烯C4和D4(LTC4和LTD4)可能是炎症损伤期间心脏功能障碍的介质,它们可能通过减少冠状动脉血流量或直接对心肌产生负面影响来降低心脏功能。我们使用恒压灌注的等容大鼠心脏标本,在输注五剂血管紧张素II、LTC4、LTD4(约10至约300 pmol·min-1)和去甲肾上腺素(400至2000 pmol·min-1)期间,或用含钙浓度减半的培养基灌注时,测量左心室舒张末压(mmHg)、冠状动脉血流量(ml·min-1)、氧摄取以及心肌氧消耗和输送量(μmol O2·[克干重]-1·min-1)。LTC4和LTD4与血管紧张素的作用相当。在低有效剂量时,氧摄取增加抵消了氧输送的减少,维持了稳定的氧消耗水平和左心室舒张末压。在最高剂量时,血管紧张素、LTC4和LTD4分别将冠状动脉血流量从21降至15、21降至13和21降至13 ml·min-1。并且,尽管血管紧张素、LTC4和LTD4的氧摄取分别增加了59%、58%和65%,但左心室舒张末压分别从基线的120 mmHg降至113、106和92。相比之下,低钙灌注降低了左心室舒张末压(从126降至92)和氧摄取(从46%降至30%),而冠状动脉血流量和氧输送没有改变。这些结果表明,LTC4和LTD4是强效的冠状动脉血管收缩剂,它们通过限制氧输送来降低心脏功能。